Personas / Equipo Humano

José Luis Dapena Díaz

Buscador de publicaciones

Publicaciones

  • Alonso-Saladrigues A, Esperanza-Cebollada E, Vicente-Garces C, Pérez-Jaume S, Sánchez-Sierra N, Richarte M, Català-Temprano A, Crespo-Carrasco A, Dapena JL, Cuatrecasas E, Faura A, Ruiz-Cobo MA, Arqués L, Conde N, Andreu S, Isola I, Jordán-García I, Garcia-Rey E, Llanos C, Marsal-Ricoma J, Celis-Passini V, Camós-Guijosa M, Torrebadell-Burriel M, Vega-García N and Rives-Solà S.

    Impact of TP53 alterations on outcomes in pediatric and young adult patients with relapsed / refractory B-cell acute lymphoblastic leukemia after CD19-CAR T-Cell therapy

    BONE MARROW TRANSPLANTATION . : .

    [doi:10.1038/s41409-026-02838-9]

  • Rivera-Perez, Cristina, Morgades, Mireia, Alonso-Saladrigues A, Montesinos, Pau, Murciano, Thais, Gil, Cristina, Adan, Rosa, Esteve, Jordi, Fuentes, Carolina, Amigo, Maria Luz, Gonzalez-Martinez, Berta, Coll, Rosa, Dapena JL, de Llano, Maria Paz Queipo, Fuster, Jose Luis, Garcia-Cadenas, Irene, Tasso, Maria, Barba, Pere, Rives-Solà S and Ribera, Josep Maria.

    Outcomes of pediatric and adult patients with relapsed/refractory cortical (CD1a+) T-cell acute lymphoblastic leukemia. The Spanish experience from SEHOP and PETHEMA groups

    ANNALS OF HEMATOLOGY . 105(4): .

    [doi:10.1007/s00277-026-06956-8]

  • Alfonso-Comos P, Briz-Redón Á, Dapena JL, Rives-Solà S, Fernández Navarro JM, Verdú-Amorós J, Cañete A and Reti-Sehop Survival Working Group.

    Spanish Paediatric Haematology and Oncology Survival Results and Trends, 1999-2022.

    Cancers . 18(3): .

    [doi:10.3390/cancers18030362]

  • Vicente-Garces C, Fernandez-Isern G, Esperanza-Cebollada E, Richarte M, Crespo-Carrasco A, Montesdeoca S, Isola I, Sarrate E, Cuatrecasas E, Rives-Solà S, Dapena JL, Camós-Guijosa M and Vega-García N.

    RNA-sequencing: A reliable tool to unveil transcriptional landscape of paediatric B-other acute lymphoblastic leukaemia

    BRITISH JOURNAL OF HAEMATOLOGY . 206(5): 1355-1365. Nº de citas: 1

    [doi:10.1111/bjh.20056]

  • Gonzalez-Bosquet E, Sánchez-Sierra, N, SANTIAGO GONZÁLEZ NÚÑEZ, Salvador-Alarcon C, Alonso-Saladrigues A, Dapena JL, Torrebadell-Burriel M, Enrique Ladera Gonzalez, Mañe, S, Planas-Roman S and Rives-Solà S.

    Uterine recurrence of acute lymphoblastic leukemia: diagnosis, treatment and literature review

    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY . 46(4): 123-128.

    [doi:10.22514/ejgo.2025.059]

  • Theron A, Alonso-Saladrigues A, Dapena JL, López-Duarte M, Diaz de Heredia C, Verdú-Amorós J, Sarrate E, Esperanza-Cebollada E, Cuatrecasas E, Andreu S, Conde N, Sanchez-Sierra N, Isola I, Camós-Guijosa M, Torrebadell-Burriel M, Rives-Solà S and Català-Temprano A.

    Secondary haematological dysplasia after CAR-T-cell therapy for acute lymphoblastic leukaemia in children.

    BRITISH JOURNAL OF HAEMATOLOGY . 206(1): 186-194.

    [doi:10.1111/bjh.19862]

  • Juan-Ribelles A, Bautista F, Cañete A, Rubio-San-Simón A, Alonso-Saladrigues A, Hladun R, Rives-Solà S, Dapena JL, Fernández JM, Lassaletta Á, Cruz-Martínez O, Ramírez-Villar G, Fuster JL, de Heredia CD, García-Ariza M, Quiroga E, Del Mar Andrés M, Verdú-Amorós J, Molinés A, Herrero B, López M, Márquez C, Toboso M, Lendínez F, Sirvent JG, Tallón M, Rodríguez G, Acha T, Moreno L and Fernández-Teijeiro A.

    ECLIM-SEHOP: how to develop a platform to conduct academic trials for childhood cancer

    Clinical & Translational Oncology . 26(9): 2351-2359.

    [doi:10.1007/s12094-024-03445-0]

  • Velasco P, Bautista F, Rubio A, Aguilar Y, Rives-Solà S, Dapena JL, Pérez A, Ramirez M, Saiz-Ladera C, Izquierdo E, Escudero A, Camós-Guijosa M, Vega-García N, Ortega M, Hidalgo-Gómez G, Palacio C, Menéndez P, Bueno C, Montero J, Romecín PA, Zazo S, Alvarez F, Parras J, Ortega-Sabater C, Chulián S, Rosa M, Cirillo D, García E, García J, Manzano-Muñoz A, Minguela A and Fuster JL.

    The relapsed acute lymphoblastic leukemia network (ReALLNet): a multidisciplinary project from the spanish society of pediatric hematology and oncology (SEHOP)

    Frontiers in Pediatrics . 11: 1269560-1269560. Nº de citas: 5

    [doi:10.3389/fped.2023.1269560]

  • Marina Caballero Bellón, Alonso-Saladrigues A, Bobillo-Perez S, Faura A, Arqués L, Rivera C, Català-Temprano A, Dapena JL, Rives-Solà S and Jordán-García I.

    Risk factors and outcome of Chimeric Antigen Receptor T-Cell patients admitted to Pediatric Intensive Care Unit: CART-PICU study

    Frontiers in Immunology . 14: 1219289-1219289. Nº de citas: 10

    [doi:10.3389/fimmu.2023.1219289]

  • Moreno C, Ramos-Elbal E, Velasco P, Aguilar Y, Gonzáález Martínez B, Fuentes C, Molinos Á, Guerra-García P, Palomo P, Verdu J, Adán Pedroso RM, Vagace JM, López-Duarte M, Regueiro A, Tasso M, Dapena JL, Salinas JA, Navarro S, Bautista F, Lassaletta Á, Lendínez F, Rives-Solà S, Pascual A, Rodríguez A, Pérez-Hurtado JM, Fernández JM, Pérez-Martínez A, González-Vicent M, Díaz de Heredia C and Fuster JL.

    Haploidentical vs. HLA-matched donor hematopoietic stem-cell transplantation for pediatric patients with acute lymphoblastic leukemia in second remission: A collaborative retrospective study of the Spanish Group for Bone Marrow Transplantation in Children (GETMON/GETH) and the Spanish Childhood Relapsed ALL Board (ReALLNet)

    Frontiers in Pediatrics . 11: 1140637-1140637. Nº de citas: 4

    [doi:10.3389/fped.2023.1140637]